Literature DB >> 1528870

A major binding protein for leukemia inhibitory factor in normal mouse serum: identification as a soluble form of the cellular receptor.

M J Layton1, B A Cross, D Metcalf, L D Ward, R J Simpson, N A Nicola.   

Abstract

A protein that specifically binds leukemia inhibitory factor (LIF) has been isolated from normal mouse serum by using four successive fractionation steps: chromatography on a LIF affinity matrix, anion-exchange chromatography, size-exclusion chromatography, and preparative native gel electrophoresis. The purified LIF-binding protein (LBP) is a glycoprotein with an apparent molecular mass of 90 kDa that specifically binds 125I-labeled murine LIF with an affinity comparable to that of the low-affinity cellular LIF receptor (Kd = 600 pM). N-terminal sequencing has identified this protein as a soluble truncated form of the alpha chain of the cellular LIF receptor. LBP is present in normal mouse serum at high levels (1 microgram/ml) and these levels are elevated in pregnant mice and reduced in neonatal mice. Since normal serum concentrations of LBP can block the biological actions of LIF in culture, LBP may serve as an inhibitor of the systemic effects of locally produced LIF.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1528870      PMCID: PMC49971          DOI: 10.1073/pnas.89.18.8616

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  17 in total

1.  A comparison of silver staining methods for detecting proteins in ultrathin polyacrylamide gels on support film after isoelectric focusing.

Authors:  L A Butcher; J K Tomkins
Journal:  Anal Biochem       Date:  1985-08-01       Impact factor: 3.365

2.  Cloning of a potentially soluble receptor for human GM-CSF.

Authors:  A Ashworth; A Kraft
Journal:  Nucleic Acids Res       Date:  1990-12-11       Impact factor: 16.971

3.  A novel family of growth factor receptors: a common binding domain in the growth hormone, prolactin, erythropoietin and IL-6 receptors, and the p75 IL-2 receptor beta-chain.

Authors:  J F Bazan
Journal:  Biochem Biophys Res Commun       Date:  1989-10-31       Impact factor: 3.575

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  The murine interleukin-4 receptor: molecular cloning and characterization of secreted and membrane bound forms.

Authors:  B Mosley; M P Beckmann; C J March; R L Idzerda; S D Gimpel; T VandenBos; D Friend; A Alpert; D Anderson; J Jackson
Journal:  Cell       Date:  1989-10-20       Impact factor: 41.582

6.  Affinity conversion of receptors for colony stimulating factors: properties of solubilized receptors.

Authors:  N A Nicola; D Cary
Journal:  Growth Factors       Date:  1992       Impact factor: 2.511

7.  Specific binding of murine leukemia inhibitory factor to normal and leukemic monocytic cells.

Authors:  D J Hilton; N A Nicola; D Metcalf
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

8.  Clonal analysis of the actions of the murine leukemia inhibitory factor on leukemic and normal murine hemopoietic cells.

Authors:  D Metcalf; D J Hilton; N A Nicola
Journal:  Leukemia       Date:  1988-04       Impact factor: 11.528

9.  Molecular cloning and expression of the murine interleukin-5 receptor.

Authors:  S Takaki; A Tominaga; Y Hitoshi; S Mita; E Sonoda; N Yamaguchi; K Takatsu
Journal:  EMBO J       Date:  1990-12       Impact factor: 11.598

10.  Leukemia inhibitory factor receptor is structurally related to the IL-6 signal transducer, gp130.

Authors:  D P Gearing; C J Thut; T VandeBos; S D Gimpel; P B Delaney; J King; V Price; D Cosman; M P Beckmann
Journal:  EMBO J       Date:  1991-10       Impact factor: 11.598

View more
  25 in total

1.  Evidence for the formation of a heterotrimeric complex of leukaemia inhibitory factor with its receptor subunits in solution.

Authors:  J G Zhang; C M Owczarek; L D Ward; G J Howlett; L J Fabri; B A Roberts; N A Nicola
Journal:  Biochem J       Date:  1997-08-01       Impact factor: 3.857

2.  Comparative time-dependent analysis of potential inflammation biomarkers in lymphoma-bearing SJL mice.

Authors:  Monica H Kristiansson; Vadiraja B Bhat; I Ramesh Babu; John S Wishnok; Steven R Tannenbaum
Journal:  J Proteome Res       Date:  2007-03-28       Impact factor: 4.466

Review 3.  Hematopoietic cytokines.

Authors:  Donald Metcalf
Journal:  Blood       Date:  2008-01-15       Impact factor: 22.113

4.  Novel neurotrophin-1/B cell-stimulating factor-3: a cytokine of the IL-6 family.

Authors:  G Senaldi; B C Varnum; U Sarmiento; C Starnes; J Lile; S Scully; J Guo; G Elliott; J McNinch; C L Shaklee; D Freeman; F Manu; W S Simonet; T Boone; M S Chang
Journal:  Proc Natl Acad Sci U S A       Date:  1999-09-28       Impact factor: 11.205

5.  IL12Rβ1ΔTM is a secreted product of il12rb1 that promotes control of extrapulmonary tuberculosis.

Authors:  Aurelie A Ray; Jeffrey J Fountain; Halli E Miller; Andrea M Cooper; Richard T Robinson
Journal:  Infect Immun       Date:  2014-11-17       Impact factor: 3.441

Review 6.  The role of the leukemia inhibitory factor receptor in neuroprotective signaling.

Authors:  Stephanie M Davis; Keith R Pennypacker
Journal:  Pharmacol Ther       Date:  2017-08-19       Impact factor: 12.310

Review 7.  Soluble receptors for cytokines and growth factors: generation and biological function.

Authors:  S Rose-John; P C Heinrich
Journal:  Biochem J       Date:  1994-06-01       Impact factor: 3.857

8.  Recent evolutionary acquisition of alternative pre-mRNA splicing and 3' processing regulations induced by intronic B2 SINE insertion.

Authors:  D Michel; G Chatelain; C Mauduit; M Benahmed; G Brun
Journal:  Nucleic Acids Res       Date:  1997-08-15       Impact factor: 16.971

9.  Leukemia inhibitory factor protects against experimental lethal Escherichia coli septic shock in mice.

Authors:  P M Waring; L J Waring; T Billington; D Metcalf
Journal:  Proc Natl Acad Sci U S A       Date:  1995-02-28       Impact factor: 11.205

10.  Alternatively spliced forms in the cytoplasmic domain of the human growth hormone (GH) receptor regulate its ability to generate a soluble GH-binding protein.

Authors:  F Dastot; M L Sobrier; P Duquesnoy; B Duriez; M Goossens; S Amselem
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.